• Profile
Close

Evaluation of treatment with 2 weeks of doxycycline on macrolide-resistant strains of Mycoplasma genitalium: A retrospective observational study

BMC Infectious Diseases Dec 11, 2021

Gossé M, Nordbø SA, Pukstad B, et al. - Treatment of Mycoplasma genitalium infections has become challenging because of increasing macrolide resistance. The effects of treatment with doxycycline 100 mg twice daily for 2 weeks have been evaluated as an alternative to moxifloxacin (an antibiotic drug used as the second-line treatment best avoided due to the potential of severe side effects and interactions).

  • Performing a retrospective observational study of medical records of patients testing positive for macrolide resistant Mycoplasma genitalium, researchers identified 263 infections from 259 patients (161 females/98 males) for inclusion in the analysis.

  • In this study, there was a higher cure rate of doxycycline than previously reported, providing additional support to doxycycline’s role in treatment prior to initiating treatment with less favorable drugs such as moxifloxacin.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay